Additional Proxy Soliciting Materials (definitive) (defa14a)
May 05 2023 - 5:30PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of the Securities
Exchange
Act of 1934
Filed
by the registrant ☒ |
Filed
by a Party other than the Registrant ☐ |
Check
the appropriate box:
|
☐ |
Preliminary
Proxy Statement |
☐ |
Confidential,
For Use |
|
☐ |
Definitive
Proxy Statement |
|
of
the Commission Only |
|
☒ |
Definitive
Additional Materials |
|
(as
permitted by Rule |
|
☐ |
Soliciting
Material under Rule 14a-12 |
|
14a-6(e)(2)) |
GT
BIOPHARMA, INC.
(Name
of Registrant as Specified in Its Charter)
(Name
of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
☒ |
No
Fee Required |
|
|
☐ |
Fee
paid previously with preliminary materials |
|
|
☐ |
Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
![](https://content.edgar-online.com/edgar_conv_img/2023/05/05/0001493152-23-015669_formdefa14a_002.jpg)
GT Biopharma (NASDAQ:GTBP)
Historical Stock Chart
From Jul 2024 to Aug 2024
GT Biopharma (NASDAQ:GTBP)
Historical Stock Chart
From Aug 2023 to Aug 2024